Literature DB >> 8774145

Detection of transforming growth factor-beta 1 in dermal lesions of different clinical forms of leprosy.

I M Goulart1, F Figueiredo, T Coimbra, N T Foss.   

Abstract

Immunohistochemical studies were performed to determine the presence and distribution of polypeptide transforming growth factor (TGF)-beta 1, a cytokine with macrophage-suppressing activity, in skin biopsies from 41 patients with different clinical forms of leprosy. We used an anti-TGF-beta 1 polyclonal antibody and the avidinbiotin-peroxidase (ABC complex) method. The results demonstrated that the lesions of the lepromatous and borderline lepromatous forms presented intense cytoplasm staining for TGF-beta 1 in the cells of the dermal infiltrate. A reaction of moderate intensity was observed in the cells of granulomas from borderline borderline cases, whereas no detectable immunoreaction was observed in granuloma cells from the tuberculoid and borderline tuberculoid forms. Considering that in the lepromatous leprosy form Mycobacterium leprae multiplies in the cytoplasm of macrophages and the lesions are diffuse and consist of poorly differentiated young macrophages, we believe that these alternations may be explained at least in part by the presence of TGF-beta 1 in the dermal infiltrate. Production of the cytokine may be induced by the presence of the bacillus itself and of its constituents, causing a mechanism of parasite evasion. Similarly, the absence of TGF-beta 1 in tuberculoid leprosy, which progresses with a specific immune response to M. leprae, may explain the intense differentiation of macrophage cells with the formation of well defined epithelioid granulomas capable of eliminating most of the bacilli.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8774145      PMCID: PMC1861719     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  34 in total

Review 1.  Transforming growth factor-beta is a potent negative regulator of human lymphocytes.

Authors:  J H Kehrl; A Taylor; S J Kim; A S Fauci
Journal:  Ann N Y Acad Sci       Date:  1991       Impact factor: 5.691

2.  Macrophage deactivating factor and transforming growth factors-beta 1 -beta 2 and -beta 3 inhibit induction of macrophage nitrogen oxide synthesis by IFN-gamma.

Authors:  A Ding; C F Nathan; J Graycar; R Derynck; D J Stuehr; S Srimal
Journal:  J Immunol       Date:  1990-08-01       Impact factor: 5.422

3.  Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones.

Authors:  P Salgame; J S Abrams; C Clayberger; H Goldstein; J Convit; R L Modlin; B R Bloom
Journal:  Science       Date:  1991-10-11       Impact factor: 47.728

4.  Infection of murine macrophages with Toxoplasma gondii is associated with release of transforming growth factor beta and downregulation of expression of tumor necrosis factor receptors.

Authors:  L E Bermudez; G Covaro; J Remington
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

5.  Transforming growth factor-beta in leishmanial infection: a parasite escape mechanism.

Authors:  M Barral-Netto; A Barral; C E Brownell; Y A Skeiky; L R Ellingsworth; D R Twardzik; S G Reed
Journal:  Science       Date:  1992-07-24       Impact factor: 47.728

6.  TGF-beta regulates production of growth factors and TGF-beta by human peripheral blood monocytes.

Authors:  N McCartney-Francis; D Mizel; H Wong; L Wahl; S Wahl
Journal:  Growth Factors       Date:  1990       Impact factor: 2.511

7.  Defining protective responses to pathogens: cytokine profiles in leprosy lesions.

Authors:  M Yamamura; K Uyemura; R J Deans; K Weinberg; T H Rea; B R Bloom; R L Modlin
Journal:  Science       Date:  1991-10-11       Impact factor: 47.728

8.  Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-beta and interleukin-10.

Authors:  C Bogdan; J Paik; Y Vodovotz; C Nathan
Journal:  J Biol Chem       Date:  1992-11-15       Impact factor: 5.157

Review 9.  Transforming growth factor beta (TGF-beta) in inflammation: a cause and a cure.

Authors:  S M Wahl
Journal:  J Clin Immunol       Date:  1992-03       Impact factor: 8.317

10.  Regulation of Trypanosoma cruzi infections in vitro and in vivo by transforming growth factor beta (TGF-beta).

Authors:  J S Silva; D R Twardzik; S G Reed
Journal:  J Exp Med       Date:  1991-09-01       Impact factor: 14.307

View more
  4 in total

1.  Immunocytochemical localization of inducible nitric oxide synthase and transforming growth factor-beta (TGF-beta) in leprosy lesions.

Authors:  S Khanolkar-Young; D Snowdon; D N Lockwood
Journal:  Clin Exp Immunol       Date:  1998-09       Impact factor: 4.330

2.  Production of transforming growth factor-beta 1 (TGF-beta1) by blood monocytes from patients with different clinical forms of leprosy.

Authors:  I M Goulart; J R Mineo; N T Foss
Journal:  Clin Exp Immunol       Date:  2000-12       Impact factor: 4.330

3.  Revisiting primary neural leprosy: Clinical, serological, molecular, and neurophysiological aspects.

Authors:  Diogo Fernandes Dos Santos; Matheus Rocha Mendonça; Douglas Eulálio Antunes; Elaine Fávaro Pípi Sabino; Raquel Campos Pereira; Luiz Ricardo Goulart; Isabela Maria Bernardes Goulart
Journal:  PLoS Negl Trop Dis       Date:  2017-11-27

4.  Type 2 leprosy reaction presenting as a monoarthritis post multidrug therapy.

Authors:  Isabela Maria Bernardes Goulart; Marcela Araujo de Oliveira Santana; Willian Vargas Tenório da Costa; Matthew Martin Pavelka; Bruno de Carvalho Dornelas
Journal:  IDCases       Date:  2022-01-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.